12/6/2021  5:35:15 PM Chg. +172.00 Volume Bid5:55:00 PM Ask5:55:00 PM Market Capitalization Dividend Y. P/E Ratio
8,363.00GBX +2.10% 172,060
Turnover(GBP): 14.32 mill.
-Bid Size: - -Ask Size: - 130.13 bill.GBP - -

Business description

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
 

Management board & Supervisory board

CEO
Pascal Soriot
Management board
Aradhana Sarin, David Fredrickson, Iskra Reic, Jeff Pott, Katarina Ageborg, Leon Wang, Menelas Pangalos, Pam Cheng, Ruud Dobber, Susan Galbraith
Supervisory board
Leif Johannson, Andreas Rummelt, Deborah DiSanzo, Diana Layfield, Euan Ashley, Marc Dunoyer, Marcus Wallenberg, Michel Demaré, Nazneen Rahman, Pascal Soriot, Philip Broadley, Sheri McCoy, Tony Mok
 

Company data

Name: AstraZeneca plc
Address: 2 Kingdom Street,UK-London W2 6BD
Phone: +44-20-7604-8000
Fax: +44-20-7604-8151
E-mail: -
Internet: www.astrazeneca.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 73.60%
IPO date: -

Investor relations

Name: Thomas Kudsk Larsen
IR phone: +44-203-749-5712
IR Fax: -
IR e-mail: IR@astrazeneca.com

Company calendar

CW 7 | 2/10/2022 4th Quarter/Annual Report
CW 18 | 4/29/2022 Interim Report 1st Quarter/3 Months
 

Main Shareholders

Freefloat
 
73.60%
BlackRock, Inc.
 
7.69%
Wellington Management Group LLP
 
4.96%
Wellington Management Company LLP
 
4.96%
The Capital Group Companies, Inc.
 
4.86%
Investor AB
 
3.93%
Others
 
0.00%